Alexion Pharmaceuticals (ALXN -1.8%) slips after Stifel Nicolaus cuts its price target on the...

|About: Alexion Pharmaceuticals, Inc. (ALXN)|By:, SA News Editor

Alexion Pharmaceuticals (ALXN -1.8%) slips after Stifel Nicolaus cuts its price target on the shares from $125 to $118. The firm says that despite posting solid top and bottom line growth last year, the timing of European aHUS reimbursements and incremental data/news flow is mostly back-weighted to the second half.